Abstract

In thrombosis and hemostasis, the formation of a platelet-fibrin thrombus or clot is a highly controlled process that varies, depending on the pathological context. Major signaling pathways in platelets are well established. However, studies with genetically modified mice have identified the contribution of hundreds of additional platelet-expressed proteins in arterial thrombus formation and bleeding. Using phenotype information of 540 mouse genes, involved in arterial thrombosis and hemostasis, we review current insights into established and novel platelet signaling mechanisms. We discuss pathways involved in platelet adhesion, shape change, integrin activation, intracellular vesicle trafficking and protein processing, granule secretion, aggregate formation, and procoagulant activity. Specific attention is paid to the signaling routes used by immunoreceptor tyrosine-based activation motif linked, immunoreceptor tyrosine-based inhibitory motif linked, and G protein–coupled receptors, as well as downstream events feeding into GTPase regulation and protein kinase activation. We further summarize known alterations in platelet responses under conditions of venous, inflammatory, and infection-dependent thrombosis, taking into account interactions of platelets with the endothelium, leukocytes, and red blood cells. Understanding the genes and proteins involved in platelet signaling in the context of hemostasis, thrombosis, and inflammation may lead to improved therapies to prevent and treat thrombotic disorders.

1.
Monroe
DM
,
Hoffman
M
.
What does it take to make the perfect clot?
.
Arterioscler Thromb Vasc Biol
.
2006
;
26
(
1
):
41
-
48
.
2.
Versteeg
HH
,
Heemskerk
JW
,
Levi
M
,
Reitsma
PH
.
New fundamentals in hemostasis
.
Physiol Rev
.
2013
;
93
(
1
):
327
-
358
.
3.
Swieringa
F
,
Spronk
HM
,
Heemskerk
JW
,
van der Meijden
PE
.
Integrating platelet and coagulation activation in fibrin clot formation
.
Res Pract Thromb Haemost
.
2018
;
2
(
3
):
450
-
460
.
4.
Van der Meijden
PE
,
Heemskerk
JW
.
Platelet biology and functions: new concepts and clinical perspectives
.
Nat Rev Cardiol
.
2019
;
16
(
3
):
166
-
179
.
5.
Staessens
S
,
Denorme
F
,
Francois
O
, et al
.
Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance
.
Haematologica
.
2020
;
105
(
2
):
498
-
507
.
6.
Chernysh
IN
,
Mukhopadhyay
S
,
Johnson
TA
, et al
.
Time-dependent ultrastructural changes during venous thrombogenesis and thrombus resolution
.
J Thromb Haemost
.
2024
;
22
(
6
):
1675
-
1688
.
7.
Welsh
JD
,
Poventud-Fuentes
I
,
Sampietro
S
,
Diamond
SL
,
Stalker
TJ
,
Brass
LF
.
Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature
.
J Thromb Haemost
.
2017
;
15
(
3
):
526
-
537
.
8.
De Witt
SM
,
Swieringa
F
,
Cavill
R
, et al
.
Identification of platelet function defects by multi-parameter assessment of thrombus formation
.
Nat Commun
.
2014
;
5
:
4257
.
9.
Baaten
CC
,
Meacham
S
,
de Witt
SM
, et al
.
A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding
.
Blood
.
2018
;
132
(
24
):
e35
-
e46
.
10.
Dubois
C
,
Panicot-Dubois
L
,
Merrill-Skoloff
G
,
Furie
B
,
Furie
BC
.
Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo
.
Blood
.
2006
;
107
(
10
):
3902
-
3906
.
11.
Eckly
A
,
Hechler
B
,
Freund
M
, et al
.
Mechanisms underlying FeCl3-induced arterial thrombosis
.
J Thromb Haemost
.
2011
;
9
(
4
):
779
-
789
.
12.
Brouns
S
,
van Geffen
JP
,
Campello
E
, et al
.
Platelet-primed interactions of coagulation and anticoagulation pathways in flow-dependent thrombus formation
.
Sci Rep
.
2020
;
10
(
1
):
11910
.
13.
Nagy
M
,
van Geffen
JP
,
Stegner
D
, et al
.
Comparative analysis of microfluidics thrombus formation in multiple genetically modified mice: link to thrombosis and hemostasis
.
Front Cardiovasc Med
.
2019
;
6
:
99
.
14.
Nurden
P
,
Stritt
S
,
Favier
R
,
Nurden
AT
.
Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy
.
Haematologica
.
2021
;
106
(
2
):
337
-
350
.
15.
Ver Donck
F
,
Labarque
V
,
Freson
K
.
Hemostatic phenotypes and genetic disorders
.
Res Pract Thromb Haemost
.
2021
;
5
(
8
):
e12637
.
16.
Chen
Y
,
Ruggeri
ZM
,
Du
X
.
14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling
.
Blood
.
2018
;
131
(
22
):
2436
-
2448
.
17.
Cranmer
SL
,
Ashworth
KJ
,
Yao
Y
, et al
.
High shear-dependent loss of membrane integrity and defective platelet adhesion following disruption of the GPIbα-filamin interaction
.
Blood
.
2011
;
117
(
9
):
2718
-
2727
.
18.
Huang
J
,
Jooss
NJ
,
Fernandez
DI
, et al
.
Roles of focal adhesion kinase PTK2 and integrin αIIbβ3 signaling in collagen- and GPVI-dependent thrombus formation under shear
.
Int J Mol Sci
.
2022
;
23
(
15
):
8688
.
19.
Auger
JM
,
Kuijpers
MJ
,
Senis
YA
,
Watson
SP
,
Heemskerk
JW
.
Adhesion of human and mouse platelets to collagen under shear: a unifying model
.
FASEB J
.
2005
;
19
(
7
):
825
-
827
.
20.
Stegner
D
,
Haining
EJ
,
Nieswandt
B
.
Targeting glycoprotein VI and the immunoreceptor tyrosine-based activation motif signaling pathway
.
Arterioscler Thromb Vasc Biol
.
2014
;
34
(
8
):
1615
-
1620
.
21.
Nagy
M
,
Perrella
G
,
Dalby
A
, et al
.
Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions
.
Blood Adv
.
2020
;
4
(
13
):
2953
-
2961
.
22.
Watson
SP
,
Auger
JM
,
McCarty
OJ
,
Pearce
AC
.
GPVI and integrin αIIbβ3 signaling in platelets
.
J Thromb Haemost
.
2005
;
3
(
8
):
1752
-
1762
.
23.
Laurent
PA
,
Severin
S
,
Gratacap
MP
,
Payrastre
B
.
Class I PI 3-kinases signaling in platelet activation and thrombosis: PDK1/Akt/GSK3 axis and impact of PTEN and SHIP1
.
Adv Biol Regul
.
2014
;
54
:
162
-
174
.
24.
Zhang
P
,
von Ungern-Sternberg
S
,
Hastenplug
L
, et al
.
Multi-phased kinetics and interaction of protein kinase signaling in glycoprotein VI-induced platelet αIIbβ3 integrin activation and degranulation
.
Thromb Haemost
.
2025
;
125
(
5
):
470
-
483
.
25.
Martin
EM
,
Zuidscherwoude
M
,
Morán
LA
,
Di
Y
,
García
A
,
Watson
SP
.
The structure of CLEC-2: mechanisms of dimerization and higher-order clustering
.
Platelets
.
2021
;
32
(
6
):
733
-
743
.
26.
Sun
S
,
Urbanus
R
,
ten Cate
H
, et al
.
Platelet-activation mechanisms and consequences of immune thrombocytopenia
.
Cells
.
2021
;
10
(
12
):
3386
.
27.
Rayes
J
,
Watson
SP
,
Nieswandt
B
.
Functional significance of the platelet immune receptors GPVI and CLEC-2
.
J Clin Invest
.
2019
;
129
(
1
):
12
-
23
.
28.
Bender
M
,
Palankar
R
.
Platelet shape changes during thrombus formation: role of actin-based protrusions
.
Hamostaseologie
.
2021
;
41
(
1
):
14
-
21
.
29.
Pleines
I
,
Cherpokova
D
,
Bender
M
.
Rho GTPases and their downstream effectors in megakaryocyte biology
.
Platelets
.
2019
;
30
(
1
):
9
-
16
.
30.
Offermanns
S
.
Activation of platelet function through G protein-coupled receptors
.
Circ Res
.
2006
;
99
(
12
):
1293
-
1304
.
31.
Gawaz
M
,
Geisler
T
,
Borst
O
.
Current concepts and novel targets for antiplatelet therapy
.
Nat Rev Cardiol
.
2023
;
20
(
9
):
583
-
599
.
32.
Leberzammer
J
,
Agten
SM
,
Blanchet
X
, et al
.
Targeting platelet-derived CXCL12 impedes arterial thrombosis
.
Blood
.
2022
;
139
(
17
):
2691
-
2705
.
33.
O'Donoghue
L
,
Smolenski
A
.
Roles of G proteins and their GTPase-activating proteins in platelets
.
Biosci Rep
.
2024
;
44
(
5
):
BSR20231420
.
34.
Jooss
NJ
,
Diender
MG
,
Fernández
DI
, et al
.
Restraining of glycoprotein VI- and integrin α2β1-dependent thrombus formation by platelet PECAM1
.
Cell Mol Life Sci
.
2024
;
81
(
1
):
44
.
35.
Smith
CW
,
Nagy
Z
,
Geer
MJ
, et al
.
LAIR-1 and PECAM-1 function via the same signaling pathway to inhibit GPVI-mediated platelet activation
.
Res Pract Thromb Haemost
.
2024
;
8
(
6
):
102557
.
36.
Coxon
CH
,
Geer
MJ
,
Senis
YA
.
ITIM receptors: more than just inhibitors of platelet activation
.
Blood
.
2017
;
129
(
26
):
3407
-
3418
.
37.
Geer
MJ
,
van Geffen
JP
,
Gopalasingam
P
, et al
.
Uncoupling of the ITIM receptor G6b-B from the tyrosine phosphatases Shp1 and Shp2 disrupts platelet homeostasis in mice
.
Blood
.
2018
;
132
(
13
):
1413
-
1425
.
38.
Heemskerk
JW
.
More than reverting tyrosine kinases
.
Blood
.
2022
;
140
(
9
):
939
-
941
.
39.
Provenzale
I
,
Solari
FA
,
Schonichen
C
, et al
.
Endothelial-mediated regulation of platelet activation: involvement of multiple protein kinases
.
FASEB J
.
2024
;
38
(
4
):
e23468
.
40.
Hornbeck
PV
,
Kornhauser
JM
,
Latham
V
, et al
.
15 years of PhosphoSitePlus: integrating post-translationally modified sites, disease variants and isoforms
.
Nucleic Acids Res
.
2019
;
47
(
D1
):
D433
-
D441
.
41.
Zou
J
,
Sun
S
,
De Simone
I
, et al
.
Platelet activation pathways controlling reversible integrin αIIbβ3 activation
.
TH Open
.
2024
;
8
(
2
):
e232
-
e242
.
42.
Shattil
SJ
,
Kim
C
,
Ginsberg
MH
.
The final steps of integrin activation: the end game
.
Nat Rev Mol Cell Biol
.
2010
;
11
(
4
):
288
-
300
.
43.
Stefanini
L
,
Paul
DS
,
Robledo
RF
, et al
.
RASA3 is a critical inhibitor of RAP1-dependent platelet activation
.
J Clin Invest
.
2015
;
125
(
4
):
1419
-
1432
.
44.
Gaspar
RS
,
Gibbins
JM
.
Thiol isomerases orchestrate thrombosis and hemostasis
.
Antioxid Redox Signal
.
2021
;
35
(
13
):
1116
-
1133
.
45.
Shattil
SJ
.
Signaling through platelet integrin αIIbβ3: inside-out, outside-in, and sideways
.
Thromb Haemost
.
1999
;
82
(
2
):
318
-
325
.
46.
Perrella
G
,
Huang
J
,
Provenzale
I
, et al
.
Non-redundant roles of platelet glycoprotein VI and integrin αIIbβ3 in fibrin-mediated microthrombus formation
.
Arterioscler Thromb Vasc Biol
.
2021
;
41
(
2
):
e97
-
e111
.
47.
Qiao
J
,
Wu
X
,
Luo
Q
, et al
.
NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis
.
Haematologica
.
2018
;
103
(
9
):
1568
-
1576
.
48.
Huang
J
,
Swieringa
F
,
Solari
FA
, et al
.
Assessment of a complete and classified platelet proteome from genome-wide transcripts of human platelets and megakaryocytes covering platelet functions
.
Sci Rep
.
2021
;
11
(
1
):
12358
.
49.
Siess
W
.
Molecular mechanisms of platelet activation
.
Physiol Rev
.
1989
;
69
(
1
):
58
-
178
.
50.
Golebiewska
EM
,
Poole
AW
.
Platelet secretion: from haemostasis to wound healing and beyond
.
Blood Rev
.
2015
;
29
(
3
):
153
-
162
.
51.
Joshi
S
,
Whiteheart
SW
.
The nuts and bolts of the platelet release reaction
.
Platelets
.
2017
;
28
(
2
):
129
-
137
.
52.
Adam
F
,
Kauskot
A
,
Kurowska
M
, et al
.
Kinesin-1 is a new actor involved in platelet secretion and thrombus stability
.
Arterioscler Thromb Vasc Biol
.
2018
;
38
(
5
):
1037
-
1051
.
53.
Fernández
DI
,
Provenzale
I
,
Canault
M
, et al
.
High-throughput microfluidic blood testing to phenotype genetically linked platelet disorders: an aid to diagnosis
.
Blood Adv
.
2023
;
7
(
20
):
6163
-
6177
.
54.
Walsh
TG
,
Li
Y
,
Williams
CM
,
Aitken
EW
,
Andrews
RK
,
Poole
AW
.
Loss of the exocyst complex component EXOC3 promotes hemostasis and accelerates arterial thrombosis
.
Blood Adv
.
2021
;
5
(
3
):
674
-
686
.
55.
Mammadova-Bach
E
,
Nagy
M
,
Heemskerk
JW
,
Nieswandt
B
,
Braun
A
.
Store-operated calcium entry in thrombosis and thrombo-inflammation
.
Cell Calcium
.
2019
;
77
:
39
-
48
.
56.
Volz
J
,
Kusch
C
,
Beck
S
, et al
.
BIN2 orchestrates platelet calcium signaling in thrombosis and thrombo-inflammation
.
J Clin Invest
.
2020
;
130
(
11
):
6064
-
6079
.
57.
Mattheij
NJ
,
Braun
A
,
van Kruchten
R
, et al
.
Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage
.
FASEB J
.
2016
;
30
(
2
):
727
-
737
.
58.
Baig
AA
,
Haining
EJ
,
Geuss
E
, et al
.
TMEM16F-mediated platelet membrane phospholipid scrambling is critical for hemostasis and thrombosis but not thromboinflammation in mice
.
Arterioscler Thromb Vasc Biol
.
2016
;
36
(
11
):
2152
-
2157
.
59.
Alberio
LJ
,
Clemetson
KJ
.
All platelets are not equal: COAT platelets
.
Curr Hematol Rep
.
2004
;
3
(
5
):
338
-
343
.
60.
Fernandez
DI
,
Kuijpers
MJ
,
Heemskerk
JW
.
Platelet calcium signalling by G-protein coupled and ITAM-linked receptors regulating anoctamin-6 and procoagulant activity
.
Platelets
.
2021
;
32
(
7
):
863
-
871
.
61.
Mattheij
NJ
,
Swieringa
F
,
Mastenbroek
TG
, et al
.
Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII
.
Haematologica
.
2016
;
101
(
4
):
427
-
436
.
62.
Solari
FA
,
Mattheij
NJ
,
Burkhart
JM
, et al
.
Combined quantification of the global proteome, phosphoproteome, and proteolytic cleavage to characterize altered platelet functions in the human Scott syndrome
.
Mol Cell Proteomics
.
2016
;
15
(
10
):
3154
-
3169
.
63.
Quach
ME
,
Chen
W
,
Li
R
.
Mechanisms of platelet clearance and translation to improve platelet storage
.
Blood
.
2018
;
131
(
14
):
1512
-
1521
.
64.
Veninga
A
,
Baaten
CC
,
De Simone
I
, et al
.
Effects of platelet agonists and priming on the formation of platelet populations
.
Thromb Haemost
.
2022
;
122
(
5
):
726
-
738
.
65.
Welsh
JD
,
Muthard
RW
,
Stalker
TJ
,
Taliaferro
JP
,
Diamond
SL
,
Brass
LF
.
A systems approach to hemostasis: 4. How hemostatic thrombi limit the loss of plasma-borne molecules from the microvasculature
.
Blood
.
2016
;
127
(
12
):
1598
-
1605
.
66.
Furie
B
,
Furie
BC
.
Mechanisms of thrombus formation
.
N Engl J Med
.
2008
;
359
(
9
):
938
-
949
.
67.
Wannemacher
KM
,
Wang
L
,
Zhu
L
,
Brass
LF
.
The role of semaphorins and their receptors in platelets: lessons learned from neuronal and immune synapses
.
Platelets
.
2011
;
22
(
6
):
461
-
465
.
68.
Taylor
KA
,
Little
G
,
Gibbins
JM
.
Mind the gap: connexins and pannexins in platelet function
.
Platelets
.
2021
;
32
(
7
):
888
-
894
.
69.
Beck
F
,
Geiger
J
,
Gambaryan
S
, et al
.
Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition
.
Blood
.
2017
;
129
(
2
):
e1
-
e12
.
70.
Kaiser
R
,
Dewender
R
,
Mulkers
M
, et al
.
Procoagulant platelet activation promotes venous thrombosis
.
Blood
.
2024
;
144
(
24
):
2546
-
2553
.
71.
Ballard-Kordeliski
A
,
Lee
RH
,
O'Shaughnessy
EC
, et al
.
4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse hemostasis model
.
Blood
.
2024
;
144
(
10
):
1116
-
1126
.
72.
Wauthier
L
,
Favresse
J
,
Hardy
M
, et al
.
D-dimer testing: a narrative review
.
Adv Clin Chem
.
2023
;
114
:
151
-
223
.
73.
Hemker
HC
,
Giesen
PL
,
Ramjee
M
,
Wagenvoord
R
,
Béguin
S
.
The thrombogram: monitoring thrombin generation in platelet-rich plasma
.
Thromb Haemost
.
2000
;
83
(
4
):
589
-
591
.
74.
Mammadova-Bach
E
,
Ollivier
V
,
Loyau
S
, et al
.
Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation
.
Blood
.
2015
;
126
(
5
):
683
-
691
.
75.
Perrella
G
,
Nagy
M
,
Watson
SP
,
Heemskerk
JW
.
Platelet GPVI (glycoprotein VI) and thrombotic complications in the venous system
.
Arterioscler Thromb Vasc Biol
.
2021
;
41
(
11
):
2681
-
2692
.
76.
Mwiza
JMN
,
Lee
RH
,
Paul
DS
, et al
.
Both G protein-coupled and immunoreceptor tyrosine-based activation motif receptors mediate venous thrombosis in mice
.
Blood
.
2022
;
139
(
21
):
3194
-
3203
.
77.
Du
VX
,
Huskens
D
,
Maas
C
,
Al Dieri
R
,
de Groot
PG
,
de Laat
B
.
New insights into the role of erythrocytes in thrombus formation
.
Semin Thromb Hemost
.
2014
;
40
(
1
):
72
-
80
.
78.
Engelmann
B
,
Massberg
S
.
Thrombosis as an intravascular effector of innate immunity
.
Nat Rev Immunol
.
2013
;
13
(
1
):
34
-
45
.
79.
Schrottmaier
WC
,
Mussbacher
M
,
Salzmann
M
,
Assinger
A
.
Platelet-leukocyte interplay during vascular disease
.
Atherosclerosis
.
2020
;
307
:
109
-
120
.
80.
Wagner
DD
,
Heger
LA
.
Thromboinflammation: from atherosclerosis to COVID-19
.
Arterioscler Thromb Vasc Biol
.
2022
;
42
(
9
):
1103
-
1112
.
81.
Von Brühl
ML
,
Stark
K
,
Steinhart
A
, et al
.
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
.
J Exp Med
.
2012
;
209
(
4
):
819
-
835
.
82.
Sachetto
AT
,
Mackman
N
.
Monocyte tissue factor expression: lipopolysaccharide induction and roles in pathological activation of coagulation
.
Thromb Haemost
.
2023
;
123
(
11
):
1017
-
1033
.
83.
Goerge
T
,
Ho-Tin-Noe
B
,
Carbo
C
, et al
.
Inflammation induces hemorrhage in thrombocytopenia
.
Blood
.
2008
;
111
(
10
):
4958
-
4964
.
84.
Kaiser
R
,
Escaig
R
,
Nicolai
L
.
Hemostasis without clot formation: how platelets guard the vasculature in inflammation, infection, and malignancy
.
Blood
.
2023
;
142
(
17
):
1413
-
1425
.
85.
Schrottmaier
WC
,
Assinger
A
.
The concept of thromboinflammation
.
Hamostaseologie
.
2024
;
44
(
1
):
21
-
30
.
86.
Assinger
A
.
Platelets and infection: an emerging role of platelets in viral infection
.
Front Immunol
.
2014
;
5
:
649
.
87.
Hamzeh-Cognasse
H
,
Damien
P
,
Chabert
A
,
Pozzetto
B
,
Cognasse
F
,
Garraud
O
.
Platelets and infections-complex interactions with bacteria
.
Front Immunol
.
2015
;
6
:
82
.
88.
McNicol
A
.
Bacteria-induced intracellular signalling in platelets
.
Platelets
.
2015
;
26
(
4
):
309
-
316
.
89.
Mussbacher
M
,
Salzmann
M
,
Brostjan
C
, et al
.
Cell type-specific roles of NF-κB linking inflammation and thrombosis
.
Front Immunol
.
2019
;
10
:
85
.
90.
Schrottmaier
WC
,
Schmuckenschlager
A
,
Pirabe
A
,
Assinger
A
.
Platelets in viral infections: brave soldiers or Trojan horses
.
Front Immunol
.
2022
;
13
:
856713
.
91.
Ramlall
V
,
Thangaraj
PM
,
Meydan
C
, et al
.
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
.
Nat Med
.
2020
;
26
(
10
):
1609
-
1615
.
92.
Althaus
K
,
Marini
I
,
Zlamal
J
, et al
.
Antibody-induced procoagulant platelets in severe COVID-19 infection
.
Blood
.
2021
;
137
(
8
):
1061
-
1071
.
93.
Vogel
S
,
Thein
SL
.
Platelets at the crossroads of thrombosis, inflammation and haemolysis
.
Br J Haematol
.
2018
;
180
(
5
):
761
-
767
.
94.
Colicchia
M
,
Schrottmaier
WC
,
Perrella
G
, et al
.
S100A8/A9 drives the formation of procoagulant platelets through GPIbα
.
Blood
.
2022
;
140
(
24
):
2626
-
2643
.
95.
Maugeri
N
,
Manfredi
AA
.
Platelet HMGB1 steers intravascular immunity and thrombosis
.
J Thromb Haemost
.
2024
;
22
(
12
):
3336
-
3345
.
96.
Simmons
J
,
Pittet
JF
.
The coagulopathy of acute sepsis
.
Curr Opin Anaesthesiol
.
2015
;
28
(
2
):
227
-
236
.
97.
Scully
M
,
Levi
M
.
How we manage haemostasis during sepsis
.
Br J Haematol
.
2019
;
185
(
2
):
209
-
218
.
98.
Yin
H
,
Stojanovic-Terpo
A
,
Xu
W
, et al
.
Role for platelet glycoprotein Ib-IX and effects of its inhibition in endotoxemia-induced thrombosis, thrombocytopenia, and mortality
.
Arterioscler Thromb Vasc Biol
.
2013
;
33
(
11
):
2529
-
2537
.
99.
Corken
A
,
Russell
S
,
Dent
J
,
Post
SR
,
Ware
J
.
Platelet glycoprotein Ib-IX as a regulator of systemic inflammation
.
Arterioscler Thromb Vasc Biol
.
2014
;
34
(
5
):
996
-
1001
.
100.
Middleton
E
,
Rowley
JW
,
Campbell
RA
, et al
.
Sepsis alters the transcriptional and translational landscape of human and murine platelets
.
Blood
.
2019
;
134
(
12
):
911
-
923
.
101.
Campbell
RA
,
Schwertz
H
,
Hottz
ED
, et al
.
Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3
.
Blood
.
2019
;
133
(
19
):
2013
-
2026
.
102.
Manne
BK
,
Denorme
F
,
Middleton
EA
, et al
.
Platelet gene expression and function in patients with COVID-19
.
Blood
.
2020
;
136
(
11
):
1317
-
1329
.
103.
Vilahur
G
,
Gutiérrez
M
,
Arzanauskaite
M
,
Mendieta
G
,
Ben-Aicha
S
,
Badimon
L
.
Intracellular platelet signalling as a target for drug development
.
Vasc Pharmacol
.
2018
;
111
:
22
-
25
.
104.
Sim
MM
,
Shiferawe
S
,
Wood
JP
.
Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis
.
Front Cardiovasc Med
.
2023
;
10
:
1272971
.
You do not currently have access to this content.
Sign in via your Institution